Feb 07, 2013
1:500
For every 500 shares held, investors received 1. The price per share adjusted from $0.10 to $0.00.
The split itself did not change the total investment value.
Enzolytics Inc. (ENZC) trades on the Other OTC in the Biotechnology industry.
Enzolytics Inc. company overviewThe latest split shown was on February 7, 2013. It was a 1-for-500 reverse split, so shareholders received 1 share for every 500 they held.
This history records 3 splits between April 8, 2009 and February 7, 2013.